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Introduction
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal neoplasms of the gastroin-
testinal (GI) tract.1 The radiologic findings of GISTs
are similar to those of previously described leiomy-
omas and leiomyosarcomas.2–4 Recently, immunore-
activity for c-kit (CD117), a tyrosine kinase growth
factor receptor, has allowed GISTs to be distinguished
from true leiomyomas, leiomyosarcomas, neurofibro-
mas or schwannomas in 95% of patients.5 The definite
identification of GISTs has become increasingly impor-
tant, because a c-kit selective tyrosine kinase inhibitor,
imatinib mesylate, has shown promise as an effective
adjuvant therapy treatment.6
The radiologic findings of GISTs have been recently
described in the radiology literature.7–9 Few articles
have attempted to correlate computed tomography
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(CT) findings with tumor grade. Tateishi et al8 reported
that the most significant CT features that predict a
high-grade GIST are an extrinsic epicenter and an
unclear boundary. Recently, anatomic site, size (maxi-
mum diameter in centimeters), and mitotic rate were
suggested as criteria for the prediction of malignancy
of GISTs.10 Kim et al11 evaluated the correlations
between these new criteria and CT features. They
reported that only tumor size had predictive value with
respect to malignant GISTs of the stomach. However,
their cases were limited to tumors of gastric origin.
The purpose of this study was to characterize the CT
findings of GISTs and determine whether some CT
characteristics are useful for predicting malignancy 
of GISTs, and to compare our results with those of
previous reports.
Methods
From August 2000 to September 2004, the medical
records at our institution of 65 patients with a histo-
logic and immunohistochemical diagnosis (CD117-
positive) of GIST were reviewed. Twenty-six patients
were excluded because CT scan was not available. Only
39 patients were enrolled in our study. CT scan data
were reviewed on a PACS (picture archiving and com-
munications system; GE Healthcare) for all patients.
Clinical data were recorded for patient age, sex, and
presenting symptoms. The institutional review board
at our hospital did not require approval or informed
patient consent for the review of medical records and
images.
CT examinations
CT examinations were performed using a Picker
PQ6000 or a Picker PQ2000 (Picker International Inc.,
Cleveland, OH, USA) scanner. Each patient received
100 mL of a nonionic contrast material (Ultravist 370
[iopromide], Schering, Berlin, Germany; Iopamiro
370, Bracco, Milano, Italy) or an ionic contrast mate-
rial (Telebrix 35, Guerbet, Aulnay, France).
In 34 patients, monophasic helical CT scan (equi-
librium phase) was obtained after the finishing of
contrast material injection by rapid dripping. The CT
scan was performed using the following parameters:
an 8- or 10-mm collimation. These patients received
about 600 mL diluted oral contrast agent routinely 1
hour before the study, and 300 mL diluted oral con-
trast agent was added immediately before CT scans.
In 5 patients, the biphasic helical CT scans were
obtained after 25 seconds (arterial phase) and 120
seconds (equilibrium phase) after the initiation of
contrast material injection by an automatic injector at
a rate of 3.5mL/sec. The CT scan was performed using
the following parameters: a 5- or 8-mm collimation,
1:1.5 table pitch, and 5- or 8-mm reconstruction inter-
val. Unenhanced images were obtained for 12 patients.
Imaging criteria
Two radiologists reviewed the CT scan images retro-
spectively, and final interpretations were reached by
consensus. CT scans were reviewed to determine the
size, contour, boundary, growth pattern, degree of
enhancement, and necrosis of the tumors. The presence
of calcification within the lesions was also recorded.
Tumor contour was categorized as round, ovoid,
or lobulated. The boundary categories were clear (a
smooth or lobular contour without surface projec-
tions) and unclear (irregular with surface projections).
The growth pattern was categorized as endoluminal,
exophytic, or equivocal. Endoluminal growth was
defined as when the tumor mass was completely con-
fined to the bowel lumen without bulging into the
extraluminal space. Conversely, exophytic growth was
defined as a mass confined to the extraluminal space
without bulging into the bowel lumen, although extrin-
sic indentation could be found. The degree of tumor
necrosis was assessed subjectively and categorized as
absent, mild (< 30% necrosis of the tumor), moderate
(between 30% and 70% necrosis of the tumor), and
severe (> 70% necrosis of the tumor). CT findings
were also evaluated for presence of bowel obstruc-
tion, abdominal lymphadenopathy, ascites, and distal
metastasis.
The pathologic diagnosis, concluded as low-grade
or high-grade malignancy, was made by an experi-
enced pathologist.
Statistical analysis
We evaluated the correlation between each CT feature
and malignancy. Patients’ demographic characteristics,
presenting symptoms, and lesion location were also
assessed. The statistical methods used included Fisher’s
exact test for categorical variables and Mann–Whitney
U test for continuous variables. Univariate logistic
regression for malignancy was performed for selected
significant factors. The level of significance used 
for inclusion in the model in multivariate logistic
regression was less than 0.25. The final multivariate
logistic regression model was made by means of back-
ward stepwise strategy using the significance value
p < 0.05 to identify significant predictors of a high-
grade GIST.
In addition, the relationship between CT features
and tumor size was assessed by means of nonparametric
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univariate analysis using the Mann–Whitney U test
for comparison of 2 groups and the Kruskal–Wallis
test for comparison of multiple groups. A p value
< 0.05 was considered statistically significant. Analyses
were performed using SPSS version 10.0 (SPSS Inc.,
Chicago, IL, USA).
Results
Patients’ demographic characteristics, presenting symp-
toms, lesion location, and CT characteristics are shown
in Table 1. Of the 39 patients with GISTs, 21 were
male (54%) and 18 were female (46%). The mean age
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Table 1. Patients’ demographic characteristics, presenting symptoms, lesion location, and computed tomographic (CT) characteristics
Low-grade malignancy (n = 9) High-grade malignancy (n = 30) p
Demographic characteristics
Gender 1.000‡
Male 5 16
Female 4 14
Age (yr) 0.234§
Mean ± SD 53.3 ± 20.2 62.8 ± 13.1
Range 20–78 35–86
Presenting symptoms 0.693‡
Symptomatic 6 22
Non-symptomatic 3 8
Lesion location 0.142||
Upper location 3 19
Esophagus 1 1
Stomach 2 18
Lower location 6 11
Small intestine 5 6
Colon and rectum 1 3
Omentum and mesentery 0 2
CT characteristics
Size* 0.016‡
≥ 5 cm 0 20
< 5 cm 9 9
Contour* 0.168‡
Round 6 11
Lobulated 2 16
Ovoid 1 2
Growth pattern† 0.433‡
Endoluminal 4 10
Exophytic 4 20
Enhancement 0.465‡
Poor 5 12
Moderate 2 4
Good 2 14
Necrosis 0.458‡
Absent 4 5
Mild 3 14
Moderate 1 4
Severe 1 7
Boundary 1.000‡
Clear 8 25
Unclear 1 5
*Tumor contour and size were difficult to evaluate in 1 patient; †equivocal growth pattern of the lesion was noted in 1 patient; ‡Fisher’s exact test;
§Mann–Whitney U test; ||upper vs. lower location, Fisher’s exact test.
at the time of presentation was 61 years (range, 20–86
years). The most common symptoms were GI bleed-
ing in 14 patients (36%), followed by abdominal pain
or discomfort in 9 patients (23%), changed bowel
habits in 2 patients (5%), chest tightness in 1 patient
(3%), dysphagia in 1 patient (3%), and palpable mass
in 1 patient (3%). In 11 patients (28%) who were
asymptomatic, tumors were detected during a peri-
odic medical check-up. When the tumor location was
divided into upper location and lower location, no
significant correlation between lesion location and
malignancy could be identified.
Thirty-six patients underwent surgical removal of
their tumor. Biopsy was performed in 2 patients because
they were not suitable for surgery. In 1 patient, the
tumor mass was scattered over the mesentery and
omentum. Due to extensive tumor spreading and the
easy bloody ooze of the tumor surface, only partial
omentectomy was done. Nine (23%) cases were classi-
fied as benign (Figure 1) and 30 (77%) as malignant
(Figures 2 and 3). The sizes of benign tumors ranged
from 2.5 to 5.0 cm (mean, 3.8 ± 0.9 cm), and those of
malignant tumors ranged from 2.5 to 22.0 cm (mean,
8.2 ± 5.3 cm).
A primary mesentery GIST in 1 patient pre-
sented with numerous nodules scattering over the
mesentery, and its contour and size were difficult to
evaluate. Another 78-year-old female with a GIST of
the jejunum presented with GI bleeding, and the
growth pattern in this patient was equivocal. The
sizes of 39 tumors ranged from 2.5 to 22.0 cm
(mean, 7.2 ± 5.0 cm). Exophytic growth pattern was
present in 24 tumors (62%). Central fluid attenuation
was present in 30 tumors (77%). Calcification (n = 1),
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Figure 1. A 58-year-old male with benign gastrointestinal stromal tumor of the stomach incidentally detected during periodic medical
check-up. Computed tomography shows well-defined and rounded endoluminal gastric tumor (arrow): (A) non-enhanced; (B) contrast-
enhanced.
A B
Figure 2. A 70-year-old male with malignant gastrointestinal stromal tumor of the small intestine presenting with gastrointestinal bleed-
ing. (A) Non-enhanced computed tomography (CT) shows a large well-defined soft tissue mass in the pelvic cavity (arrow). (B) Contrast-
enhanced CT obtained during arterial phase shows a lobulated hypervascular tumor with severe central necrosis (arrow).
lymphadenopathy (n = 1), and ascites (n = 1) were seen
in malignant lesions. Bowel obstruction was not pres-
ent in these 39 patients.
Three patients had metastatic lesions on CT scans
at first presentation. They were diagnosed with liver
metastasis, and 1 of them also had peritoneal tumor
seeding. The primary tumor origins of these patients
were stomach, duodenum, and jejunum, with tumor
sizes of 22.0 cm, 6.0 cm, and 6.8 cm, respectively. Liver
metastasis was visualized as a peripheral hypervascular
soft tissue component with central fluid attenuation
in 1 patient and hypoattenuation in comparison with
the normal surrounding parenchyma on equilibrium
phase in 2 patients.
Old age and larger tumor size (≥ 5 cm) were statis-
tically significant in the univariate logistic analysis for
malignant tumors (p < 0.25). In multivariate logistic
regression by means of backward stepwise strategy,
only larger tumor size (≥ 5 cm) was found to have final
statistical significance for malignant GISTs (p < 0.05).
The relationships between CT features and tumor
size are listed in Table 2. Exophytic lesions had larger
size than endoluminal lesions (p < 0.001). Lesions with
lobulated appearance had larger size than those with
round appearance (p < 0.01). Well-enhanced tumors
had larger size than poor-enhanced ones (p < 0.05).
The greater the necrosis of a tumor, the more it pre-
sented with larger size (p < 0.01).
Discussion
GISTs, previously classified as leiomyomas or
leiomyosarcomas, are the most common mesenchymal
tumors of the GI tract.1 Recent studies suggest that
GISTs have unique immunohistochemical and molec-
ular genetic features that set them apart from typical
smooth muscle tumors and schwannomas. C-kit
(CD117), a tyrosine kinase growth factor receptor, is
the most specific and important immunohistochemi-
cal marker for GISTs.12 The availability of the tyro-
sine kinase inhibitor (STI-571, imatinib [Gleevec];
Novartis, Basel, Switzerland) has altered the clinical
approach to GISTs because it has been proven to be
effective in the medical treatment of unresectable or
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Figure 3. A 49-year-old male with a pathologically proven malignant gastrointestinal stromal tumor incidentally detected for clinical indi-
cations of other diseases. (A) Contrast-enhanced computed tomography (CT) obtained during arterial phase shows a solid and lobu-
lated hypervascular mass in the proximal jejunum (arrow). (B) Contrast-enhanced CT obtained during arterial phase shows metastatic
liver masses (arrows) with peripheral heterogeneous enhancement and central fluid attenuation.
Table 2. Computed tomographic (CT) features and tumor size*
n
Mean tumor 
95% CI
size (cm)
CT characteristics
Growth pattern
Endoluminal 14 4.2 ± 1.1 3.6–4.8
Exophytic 23 9.2 ± 5.5 6.8–11.6
Contour
Round 17 4.4 ± 1.3 3.7–5.0
Lobulated 18 9.8 ± 5.8 6.9–12.7
Degree of enhancement
Poor 16 6.0 ± 4.7 3.6–8.5
Moderate 6 4.6 ± 1.2 3.3–5.8
Good 16 9.3 ± 5.5 6.4–12.2
Necrosis
Absent 8 3.6 ± 0.8 3.0–4.3
Mild 17 6.1 ± 3.4 4.4–7.9
Moderate 5 8.3 ± 5.1 2.1–14.6
Severe 8 12.3 ± 6.5 6.8–17.7
*Mann–Whitney U test for comparison of 2 groups by Bonferroni method,
and Kruskal–Wallis test for comparison of multiple groups. CI = confidence
interval.
metastatic GISTs.6 Therefore, the detection of liver
metastasis or prediction of tumor malignancy has
become more important than ever.
Although some reports in the literature show that
GIST has a male predominance,7,9 others, such as the
present study, show no gender predilection.4,8,11 The
most common clinical manifestation of a symptomatic
GIST in our series was GI bleeding. This is compati-
ble with previous reports.1 Patients may present with
hematemesis, melena, or signs and symptoms of ane-
mia caused by occult bleeding. In other reports, the
most common symptom was abdominal pain.8,11 Many
GISTs are incidentally found during a periodic med-
ical check-up, and some of them may be diagnosed
after complaint of abdominal pain or discomfort, but
not recorded in the chart, which may provide an expla-
nation for discrepancies concerning the most common
symptoms.
Anatomic site, size (maximum diameter in cen-
timeters), and mitotic rate were recently suggested as
criteria for the prediction of GIST malignancy.10 In
our series, the most common location was the stom-
ach (51%), followed by small intestine (28%), col-
orectum (10%), esophagus (5%), and omentum and
mesentery (5%). The results were similar to those of
previous studies.13,14 According to previous reports,
the criteria for malignancy differed according to
whether tumors were gastric or intestinal. It has been
reported that GISTs arising in the small intestine
show more malignant behavior than GISTs arising in
the stomach.10,15 However, in our series, no significant
correlation existed between lesion location and malig-
nancy. One possible explanation is the small sample size
in our series. In a previous report, most (approximately
70%) gastric GISTs behaved in a benign fashion.16
However, in our series, the incidence of high-grade
malignant gastric GISTs was 90%, higher than in most
of the previous reports. Such a high incidence of malig-
nant gastric GISTs was also observed in the study of
Kim et al.11 This can explain why location was not a
significant predictor of malignancy in our series.
Some authors have postulated no correlation
between CT findings and malignant potential unless
an obvious local invasion or metastatic lesion is seen.1,17
The liver is the most common metastatic site at both
presentation and disease relapse.7 In our series, 3
patients had metastatic lesions on CT scans at first
presentation. The pathologic diagnoses of these 3
GISTs were all malignancy. Horton et al16 reported that
imaging during the portal venous phase was usually
adequate for detecting liver metastasis. In addition,
arterial phase imaging may be helpful for evaluation of
tumor enhancement or surgical planning. However,
we may have missed some liver lesions that may have
been isodense on portal venous or equilibrium-phase
images. This is a limitation of our study.
Chun et al4 observed that CT features of size, con-
tour, enhancing pattern, mesenteric fat infiltration,
ulceration, regional lymphadenopathy, and exophytic
growth pattern could be used to differentiate between
malignant and benign tumors. Multivariate analysis
was not performed in their report. Tateishi et al8 and
Kim et al11 performed univariate and multivariate analy-
ses of CT features to differentiate between malignant
and benign tumors. Tateishi et al8 reported that an
extrinsic epicenter and an unclear boundary were the
most significant predictors of high-grade GIST. Kim
et al11 reported that presence of an ulcer, mesenteric
fat infiltration, direct organ invasion, and metastasis
were more frequently observed in GISTs of the stom-
ach with a high mitotic rate, but tumor size was the
only significant predictor of a high mitotic rate; how-
ever, their cases were limited to tumors of gastric origin.
In our series, however, multiple logistic regression
analysis showed that larger tumor size (≥ 5.0 cm) was
the only predictor of malignant GIST. The average
tumor size in our series was 7.2 ± 5.0 cm. The average
tumor sizes in our series and the study by Kim et al
are larger than that of the study by Tateishi et al, and
tumor size was the only significant predictor concern-
ing malignancy in our series and the study of Kim 
et al. We boldly assume that the larger the tumor mass,
the more important is lesion size as a predictor con-
cerning malignancy. This hypothesis can be roughly
proven in the study by Kim et al,11 who reported that,
for a subgroup of 36 tumors ≤ 5 cm, differentiation of
benign from malignant was not possible using CT,
including by tumor size.
Our results also showed that larger tumors had a
tendency to grow exophyticly and show lobulated
contour, whereas smaller ones tended to grow endo-
luminally and show round contour. This is compati-
ble with a previous report.11 Good enhancement was
also observed in the larger tumors in our series.
In the study by Tateishi et al,8 statistically signifi-
cant CT findings of high-grade tumors included het-
erogeneous enhancement pattern. The series by Chun
et al4 also demonstrated the same result. However, in
the study by Kim et al,11 heterogeneous enhancement
pattern was not a significant predictor of malignancy.
We used tumor necrosis as a predictor instead of
enhancement pattern because biphasic helical CT scans
were obtained in only 5 patients in our series. We
assumed that the degree of necrosis would affect the
J Chin Med Assoc • September 2007 • Vol 70 • No 9372
T.H. Yang, et al
enhancement pattern. We graded necrosis as absent,
mild, moderate, or severe. To our knowledge, no pre-
vious reports graded necrosis from CT imaging as a
predictor. Although in the multivariate analysis in our
series, tumor necrosis was not a significant predictor
of malignancy, in the later statistical analysis, we found
the larger tumor masses were more necrotic.
Our study had an additional limitation. This was a
retrospective study in which data were gathered over a
period of years, with substantial variations in CT equip-
ment and method. Nevertheless, given the relatively
low frequency of occurrence of GISTs at any single
institution, the prospective acquisition of a similar num-
ber of cases may require a large multi-institutional
study conducted over many years.
In conclusion, we observed statistically significant
difference in CT findings between malignant and
benign GISTs. Larger tumor size (≥5cm) was found to
have predictive value with respect to GIST malignancy.
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